The Janus kinase inhibitor baricitinib, in combination with narrowband ultraviolet B therapy, improved vitiligo, according to ...
In a phase 2 clinical trial, researchers examined baricitinib and NB-UVB in adults with severe vitiligo in the dermatology ...
Combining baricitinib with narrowband UVB phototherapy led to significant repigmentation and enhanced quality of life in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results